Efficacy and safety of coadministered onceweekly cagrilintide 2.4 mg with onceweekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, doubleblind, activecontrolled, phase 2 trial
For them and thousands of potential patients, a generic injectable for weight loss is a welcome and much-needed addition to available medical options
Months 1-2 (Initial Titration): Maintain weights from before starting medication Focus on consistent training despite side effects Priority is showing up, not pushing intensity If you miss workouts due to nausea, dont compensate by training harder Months 3-6 (Adaptation Phase): Attempt modest strength increases (2.5-5 pounds on upper body, 5-10 pounds on lower body every 3-4 weeks) If strength stalls, thats acceptable maintenance is success Increase reps before increasing weight (if you can do 12 reps with good form, add weight) Months 7-11 (Maintenance Phase): Continue training at maintained strength levels Accept that weight loss velocity is slowing Focus shifts to body composition refinement Consider adding 1 additional set per exercise if recovery permits MY UNCONVENTIONAL RECOMMENDATION I actually tell patients to stop tracking their one-rep maxes during Retatrutide treatment
While dramatic, this pace is difficult to sustain and disproportionately affects lean mass
This article provides evidence-based guidance on using ibuprofen with Wegovy, explores how each medication works, discusses important safety considerations, and outlines when to seek professional medical advice
Semaglutide injection and other GLP-1 receptor agonists have become widely used for weight loss, but pregnancy changes the clinical picture entirely
